{"license":"https://creativecommons.org/licenses/by/4.0/","dataset":"event-entities","count":3,"summary":{"policyEntityCount":21,"relationshipCount":31,"officialEventCount":14,"linkedEventCount":12,"unlinkedEventCount":2,"marketCount":7,"sourceCount":11,"agencyCount":4,"profileCrosswalkCount":6,"firstYear":2019,"latestYear":2026,"spanLabel":"2019-2026"},"guardrail":"A relationship means an official source names the organization in connection with the dated record. It does not by itself establish liability, market power, ownership, control, or that the organization participates in every market linked to that record.","crosswalkGuardrail":"Optional participant and operator crosswalks are observatory navigation aids based on matched public labels. They are not legal-entity, affiliate, beneficial-owner, or corporate-control determinations.","policyEntityFilters":{"policyEntity":"caremark-rx-llc","policyEntityMatched":true,"entityId":"pent-caremark-rx","slug":"caremark-rx-llc","name":"Caremark Rx, LLC","role":null,"roleMatched":null},"rows":[{"id":"peel-caremark-settlement","eventId":"evt-pbm-caremark-settlement-2026","eventDate":"2026-07-14","eventTitle":"FTC announces proposed consent agreement with Caremark","eventStage":"remedy","eventType":"settlement","agency":"Federal Trade Commission","docketNumber":"Docket No. 9437","entityId":"pent-caremark-rx","entitySlug":"caremark-rx-llc","entityName":"Caremark Rx, LLC","role":"remedy_subject","roleLabel":"Remedy subject","evidenceSummary":"The FTC settlement announcement identifies Caremark among the entities subject to the proposed consent agreement.","markets":[{"id":"mkt-pbm","slug":"us-pharmacy-benefit-management","name":"U.S. pharmacy benefit management"}],"sourceId":"ftc-caremark-settlement-2026","sourceTitle":"FTC Secures Major Settlement with Caremark Resolving Antitrust Case Against Second Drug Middleman","sourcePublisher":"Federal Trade Commission","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2026/07/ftc-secures-major-settlement-caremark-resolving-antitrust-case-against-second-drug-middleman","sourceAccessDate":"2026-07-20","profileHref":null,"profileKind":null,"policyEntityProfileHref":"/enforcement/entities/caremark-rx-llc","recordProfileHref":"/enforcement/records/pbm-caremark-settlement-2026","enforcementHref":"/enforcement?policyEntity=caremark-rx-llc&enforcementEvent=evt-pbm-caremark-settlement-2026#enforcement-relationship-atlas","guardrail":"A relationship means an official source names the organization in connection with the dated record. It does not by itself establish liability, market power, ownership, control, or that the organization participates in every market linked to that record.","crosswalkGuardrail":"Optional participant and operator crosswalks are observatory navigation aids based on matched public labels. They are not legal-entity, affiliate, beneficial-owner, or corporate-control determinations.","sourceProfileHref":"/sources/ftc-caremark-settlement-2026"},{"id":"peel-caremark-complaint","eventId":"evt-pbm-insulin-complaint-2024","eventDate":"2024-09-20","eventTitle":"FTC files administrative complaint against the three largest PBMs","eventStage":"litigation","eventType":"complaint","agency":"Federal Trade Commission","docketNumber":"Docket No. 9437","entityId":"pent-caremark-rx","entitySlug":"caremark-rx-llc","entityName":"Caremark Rx, LLC","role":"respondent","roleLabel":"Respondent","evidenceSummary":"The FTC administrative complaint names Caremark Rx as a respondent.","markets":[{"id":"mkt-pbm","slug":"us-pharmacy-benefit-management","name":"U.S. pharmacy benefit management"}],"sourceId":"ftc-pbm-insulin-complaint-2024","sourceTitle":"FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices","sourcePublisher":"Federal Trade Commission","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/09/ftc-sues-prescription-drug-middlemen-artificially-inflating-insulin-drug-prices","sourceAccessDate":"2026-07-17","profileHref":null,"profileKind":null,"policyEntityProfileHref":"/enforcement/entities/caremark-rx-llc","recordProfileHref":"/enforcement/records/pbm-insulin-complaint-2024","enforcementHref":"/enforcement?policyEntity=caremark-rx-llc&enforcementEvent=evt-pbm-insulin-complaint-2024#enforcement-relationship-atlas","guardrail":"A relationship means an official source names the organization in connection with the dated record. It does not by itself establish liability, market power, ownership, control, or that the organization participates in every market linked to that record.","crosswalkGuardrail":"Optional participant and operator crosswalks are observatory navigation aids based on matched public labels. They are not legal-entity, affiliate, beneficial-owner, or corporate-control determinations.","sourceProfileHref":"/sources/ftc-pbm-insulin-complaint-2024"},{"id":"peel-caremark-report","eventId":"evt-pbm-interim-report-2024","eventDate":"2024-07-09","eventTitle":"FTC releases interim staff report on prescription drug middlemen","eventStage":"monitoring","eventType":"report","agency":"Federal Trade Commission","docketNumber":null,"entityId":"pent-caremark-rx","entitySlug":"caremark-rx-llc","entityName":"Caremark Rx, LLC","role":"report_subject","roleLabel":"Report subject","evidenceSummary":"The FTC interim report identifies Caremark Rx among the six PBMs that received Section 6(b) orders.","markets":[{"id":"mkt-pbm","slug":"us-pharmacy-benefit-management","name":"U.S. pharmacy benefit management"}],"sourceId":"ftc-pbm-interim-2024","sourceTitle":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies","sourcePublisher":"Federal Trade Commission","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/07/ftc-releases-interim-staff-report-prescription-drug-middlemen","sourceAccessDate":"2026-05-16","profileHref":null,"profileKind":null,"policyEntityProfileHref":"/enforcement/entities/caremark-rx-llc","recordProfileHref":"/enforcement/records/pbm-interim-report-2024","enforcementHref":"/enforcement?policyEntity=caremark-rx-llc&enforcementEvent=evt-pbm-interim-report-2024#enforcement-relationship-atlas","guardrail":"A relationship means an official source names the organization in connection with the dated record. It does not by itself establish liability, market power, ownership, control, or that the organization participates in every market linked to that record.","crosswalkGuardrail":"Optional participant and operator crosswalks are observatory navigation aids based on matched public labels. They are not legal-entity, affiliate, beneficial-owner, or corporate-control determinations.","sourceProfileHref":"/sources/ftc-pbm-interim-2024"}]}